newsfilter
← Latest News
PR Newswire·

Ampio Pharmaceuticals Issues Letter to Stockholders

ENGLEWOOD, Colo., Aug. 3, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi and Chief Executive Officer, Mike Martino.